Anti-Alzheimer’s Disease activity: In vitro AChE and BChE inhibitory activitiesAChE1: IC50 = 67.41 ± 1.52 μM3: IC50 = 25.02 ± 0.95 μMDonepezil (positive control): IC50 = 0.07 ± 0.00 μMBChE1: IC50 = 27.16 ± 0.06 μM3: IC50 = 22.36 ± 0.03 μMDonepezil (positive control): IC50 = 4.73 ± 0.91 μMKiAChE and KiBChE3: 25.01 μM and 22.36 μM. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.